Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bristol-Myers Squibb patents activin receptor-like kinase 5 inhibitors

March 17, 2017

Takeda Pharmaceutical patents histone deacetylase inhibitors

March 15, 2017

University of California, Oakland presents nitroxide spin-labeled compounds targeting beta-amyloid

March 15, 2017

Portola Pharmaceuticals presents novel PCSK9 inhibitors

March 14, 2017

Sichuan Kelun Pharmaceutical Research Institute discovers dipeptidyl peptidase 4 inhibitors

March 14, 2017

Pfizer patents IRAK-4 inhibitors

March 14, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

March 14, 2017

GlaxoSmithKline presents new antibacterials

March 13, 2017

Astellas patents alpha-7 nicotinic receptor positive allosteric modulators

March 13, 2017

Shanghai Institute Materia Medica divulges pyridazinone compounds for HBV infection

March 13, 2017

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...